The medical device manufacturer has reported a significant increase in revenues and a path to profitability, driven by growth in its Biomaterials and Contract Manufacturing divisions.
The medical device firm has achieved break-even, with an 88% revenue surge and strategic acquisition, signaling a turnaround in its financial performance and positioning for future growth.
The medical device company has announced that its Chief Financial Officer has purchased additional shares in the business.
The medical device company reports strong revenue growth and improved profitability, with opportunities for further expansion in its contract manufacturing and biomaterials businesses.
The medical device company announces its CEO has purchased additional shares, a move that could signal confidence in the business.
The medical device company reports positive financial performance from its recently acquired French subsidiary, with revenue growth, improved profitability, and operational enhancements.
The medical device company has secured a major new supply agreement, potentially worth £3.3 million over five years, representing a significant increase in business with an existing customer.
The medical device company reported a 92% revenue increase, expanded gross margins, and a return to profitability in its interim results. A strategic acquisition was completed at favorable terms, strengthening its market position.
The medical device company reported substantial revenue growth and a return to profitability in the first half, driven by strong performance across its business units.
Medical device company RUA Life Sciences expands its contract manufacturing and product portfolio with the acquisition of Abiss, a French manufacturer of implantable devices.